What You Should Know
Boehringer Ingelheim and Eko Health have introduced Eko Vet+™ | CANINEBEAT® AI, a digital auscultation solution designed to detect, visualize, and grade heart murmurs in dogs.The system utilizes the Eko CORE™ Digital Attachment, which amplifies heart sounds by 40 times and offers advanced noise cancellation.The CANINEBEAT® AI algorithm boasts over 95% sensitivity and specificity in detecting murmurs associated with structural heart disease.The solution targets myxomatous
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Aidoc Secures $150M to Accelerate Enterprise-Scale Clinical AI Across 2,000 Hospitals
What You Should Know
Aidoc has raised $150M in Series E funding, led by Growth Equity at Goldman Sachs Alternatives, bringing its total funding to over $500M. The round included participation from General Catalyst, SoftBank Investment Advisors, and NVentures (NVIDIA's venture capital arm).Capital will be used to further develop Aidoc's CARE™ clinical foundation model and its aiOS™ enterprise platform.The company currently analyzes more than 60 million patient cases annually and is deployed
Read More
Operationalizing Precision Medicine 2026: U.S. Health Systems Scale Genetic Testing and AI Integration
What You Should Know
Precision medicine has transitioned from "one-off" testing to organized institutional programs at more than three-quarters of surveyed U.S. health systems, according to new research from the Center for Connected Medicine (CCM) at UPMC.This represents a massive shift from 2020, when 69% of organizations had little to no precision medicine deployment.While adoption is high, reimbursement uncertainty, high costs, and operational complexity remain the primary barriers to
Read More
CareDx to Acquire Naveris for $160M to Expand into HPV-Driven Cancer MRD Monitoring
What You Should Know
CareDx has entered into a definitive agreement to acquire Naveris, a precision oncology company specializing in blood-based monitoring for viral-mediated cancers.The deal includes $160M in up-front cash, with potential for an additional $100M based on future revenue milestones.Naveris’ flagship platform utilizes Tumor Tissue Modified Viral (TTMV®) DNA to detect and monitor HPV-driven cancers with high accuracy.The acquisition is expected to close in the third quarter of
Read More
Rad AI Appoints David Leonard as COO and Elizabeth Bergey, MD, as First Chief Clinical Officer
What You Should Know
Rad AI has appointed David Leonard as Chief Operating Officer (COO) and Elizabeth Bergey, MD, as the company’s first Chief Clinical Officer (CCO).Leonard, previously Head of Operations, Strategy, and Investor Relations, will focus on scaling internal infrastructure and enhancing go-to-market strategies for AI-enabled reporting.Dr. Bergey, a board-certified radiologist and former CEO of Quantum Radiology, transitions from Chief Medical Innovation Officer to lead clinical
Read More
Rula State of Mental Health Report 2026: Financial Stress and AI Chatbot Trends in Behavioral Healthcare
What You Should Know
Rula has published its 2026 report, "State of Mental Health Report," based on a national survey of over 2,037 U.S. adults.A widening "Awareness-Action Gap" persists: while 60% of Americans value mental health more now than five years ago, fewer than half (47.4%) have ever accessed services.Financial Stress is a primary inhibitor, with 25% of respondents citing cost as their top barrier and 50% cutting back on health spending due to inflation.AI Chatbots are emerging as a
Read More
Weave Bio Launches AI-Native NDA Submission Support in Strategic Partnership with Parexel
What You Should Know
Weave Bio has expanded its AI-native regulatory platform to support New Drug Application (NDA) submissions, covering the full drug development lifecycle.Strategic partner Parexel co-developed and refined the platform, resulting in authoring speeds that are 60% faster than traditional manual methods.The platform utilizes AI-native data extraction, content verification, and automated authoring to synthesize clinical, non-clinical, and manufacturing data.Parexel will
Read More
Talkiatry and New York Cancer & Blood Specialists Partner to Expand Mental Health Access for Oncology Patients
What You Should Know
New York Cancer & Blood Specialists (NYCBS) has partnered with Talkiatry to provide integrated, high-quality psychiatric care to oncology and hematology patients.The collaboration will roll out across more than 30 NYCBS locations throughout New York, ensuring patients can access mental health support as a core part of their treatment.Talkiatry’s network of over 300 board-certified psychiatrists will provide both in-person and virtual consultations, accepting most
Read More
Flatiron Health and COA Study: Community Oncology Survival Rates Outperform SEER National Benchmarks
What You Should Know
Patients with metastatic breast cancer and non-small cell lung cancer (mNSCLC) treated in independent community oncology practices lived longer than national benchmarks.Median survival for metastatic breast cancer patients in community settings was eight months longer than the national SEER benchmark.For patients with mNSCLC, median survival in community practices was two months longer than national standards.The study analyzed real-world data from nearly 98,000 patients
Read More
UChicago Medicine Partners with Artisight to Deploy Smart Hospital Platform Across 1,800 Patient Rooms
What You Should Know
UChicago Medicine has signed an enterprise agreement to deploy Artisight’s Smart Hospital Platform, implementing more than 1,800 devices across its clinical enterprise.The rollout covers diverse care settings, including patient rooms, operating rooms, PACUs, and a new 575,000-square-foot freestanding cancer facility opening in April 2027.The platform utilizes computer vision, voice recognition, and RTLS (Real-Time Location Services) to automate documentation and support
Read More
